Bio-Europe

News

Senior figures in European biopharma think dealmaking and M&A will increase in the region, and could be helped by US policy uncertainties.

Sales & Marketing

Media Partner

2026 marks a significant evolution for BIO-Europe.

R&D

Parexel's Paul Bridges & Charlotte Moser discuss Europe's biotech sector in the face of an innovation cliff.

Market Access

Marjorie Sidhoum, vice president of business development & corporate communication at Kainova Therapeutics, discusses their immuno-oncology pipeline.

Digital

Dr Olga Nissan, vice president of business development at Evogene discusses collaboration with Google Cloud & generative design of small molecules.

Market Access

At BIO-Europe, the session “From Roasts to Billions: Biopharma Investment Landscape” brought together leading voices from investment banking & VC.